Body mass index (BMI) values that are above average and the development of overweight from childhood to adulthood are risk factors for gestational hypertension and pre-eclampsia, but normalizing BMI from childhood to conception reduces such risks, according to a study.
Accelerometer-assessed moderate-to-vigorous physical activity (MVPA) at baseline shows an inverse relationship with incident diabetes among individuals aged ≥50 years, a recent study involving a US Hispanic/Latino population has found.
Patients with acute ischaemic stroke undergoing endovascular treatment are at heightened risk of poor functional outcome and symptomatic intracranial haemorrhage (sICH) in the presence of hyperglycaemia at admission, a study has found.
Undergoing in-facility physical activity (PA) programmes initiated before the 20th week of gestation helps reduce the risk of developing gestational diabetes mellitus (GDM) among high-risk mothers, according to the results of a meta-analysis.
Treatment with sodium-glucose cotransporter-2 inhibitors (SGLT2i) results in a lower risk of clinically relevant cardiovascular death, heart failure (HF) hospitalization, and HF symptoms with similar rates of adverse events (AEs), results of a meta-analysis have shown.
Exenatide once weekly provides effective glucose control and weight loss in patients with type 2 diabetes mellitus, and these benefits are sustained through 18 months of treatment, according to real-world data.
Women who are overweight or obese do not necessarily have lower chances of a successful birth following infertility treatments, including intrauterine insemination, relative to women with normal weight, a study has found.
Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.